Status:
COMPLETED
Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
CardioMag Imaging
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
A magnetocardiograph (MCG) is a device capable of recording of magnetic fields arising from the electrical activity of the heart with traces similar to an electrocardiogram (ECG). This system was deve...
Detailed Description
Coronary Artery Disease is the leading cause of death in the United States. The non invasive detection of Acute Coronary Syndromes (ACS's) remains a clinical challenge. Electrocardiogram (ECG) may onl...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients classified as having High Risk Unstable Angina according to the ACCIAHA guidelines.
- Age ≥ 18 years.
- Exclusion criteria:
- Hemodynamically unstable patients.
- Patients who just prior to or just after admission exhibit tachycardia with heart rates exceeding 150 bpm.
- Patients with third degree AV Block.
- Patients with pacemakers or internal cardiac defibrillators.
- Patients who cannot lie in a supine position for the MCG examination.
- Patients who refuse entry into the registry
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT00169975
Start Date
August 1 2004
End Date
February 1 2008
Last Update
July 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905